Table: Cyfuse Biomedical - 9-MTH parent results

Cyfuse Biomedical KK

14/11/2024 07:03

Nov 14 (Reuters)- 
             Cyfuse Biomedical K.K. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Sep 30, 2024        Sep 30, 2023       Dec 31, 2024  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            26 mln              29 mln             60 mln     
                 (-11.5 pct)         (-91.3 pct)        (-1.4 pct)   
  Operating     loss 674 mln        loss 528 mln       loss 926 mln  
  Recurring     loss 662 mln        loss 532 mln       loss 901 mln  
  Net           loss 664 mln        loss 534 mln       loss 904 mln  
  EPS          loss 82.80 yen      loss 68.47 yen    loss 112.76 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Cyfuse Biomedical K.K.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T